What You Should Know: - Medidata, a Dassault Systèmes company, and Boehringer Ingelheim, today announced a five-year renewal of their collaboration in the wider area of electronic data capture. The agreement extends the use of Rave EDC for Boehringer Ingelheim's clinical trials worldwide and includes myMedidata, Medidata’s suite of patient-facing technologies focused on enhancing patient centricity and diversity in decentralized clinical trials (DCTs). - The
Read More
Medidata Launches New Clinical Operations Technologies
What You Should Know: - Today, Medidata, a Dassault Systèmes company, is announcing technology enhancements that address key issues in clinical trial management and oversight. - These enhancements are to Medidata Detect and Rave CTMS (Clinical Trial Management System), which will improve both data oversight and reporting for sponsors and contract research organizations (CROs) in two meaningful ways: how they comprehensively monitor their trial data, and how they
Read More
Labcorp & Medidata to Co-Develop Digital Biomarkers & Expand Decentralized Clinical Trials
What You Should Know: - Medidata, a Dassault Systèmes company, today announced that Labcorp, a leading global life sciences company, has selected Medidata's technology platform to extend their 14-year partnership, the foundation of their initiative to co-develop digital biomarkers and expand the use and functionality of decentralized clinical trials. Labcorp Drug Development has developed its offerings on Medidata technologies, starting with Rave EDC
Read More
Medidata, Parexel Expands Partnership to Enhance Decentralized Clinical Trial Delivery
What You Should Know: - Medidata, a Dassault Systèmes company and Parexel, a global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance patient health extends their 15-year global strategic partnership. This extension includes gaining access to Medidata’s continued innovations in clinical trial technology solutions with its unified platform, support of decentralized clinical trials (DCTs), the myMedidata patient portal, Sensor
Read More
Rho Selects Medidata’s Decentralized Clinical Trials Capabilities
What You Should Know: - Today, Medidata, a Dassault Systèmes company, announced that Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, is using Medidata to standardize its clinical trial platform for building out its decentralized clinical trial (DCT) technology offerings. This will enable Rho to provide rapid reporting of cross-domain, cross-study data in decentralized trials, where data collection methods have become more
Read More
Medidata, Labcorp Partner to Expand Decentralized Clinical Trials for Digital Biomarker Discovery
What You Should Know: - Medidata, a Dassault Systèmes company, today announced a first-of-its-kind partnership with Labcorp using the Medidata Sensor Cloud to introduce a new model to advance the use of medical-grade sensors in clinical trials and accelerate biomarker discovery. - As part of the partnership, Medidata will receive and process medical-grade sensor data within drug, vaccine and device trials across Labcorp Drug Development’s clinical trial portfolio,
Read More
Medidata Announces Decentralized Clinical Trials Program
What You Should Know: - Today Medidata, a Dassault Systèmes company, announced the launch of the Medidata Decentralized Clinical Trials (DCT) Program, the most comprehensive set of unified, secure technologies that enable full decentralization across the clinical trial continuum. For the first time ever, drug, vaccine, and medical device developers (sponsors) and contract research organizations (CROs) can take advantage of the only platform offering on the market which combines: -
Read More
Medidata Acquires Digital Biomarker Business of MC10 / Clinical Trials & Wearable Sensors
What You Should Know: - Clinical trials technology company Medidata has
acquired the digital biomarker business of MC10. - MC10’s offerings will bring novel clinical analytics
and biosensor capabilities to Medidata’s existing technology solutions,
enhancing Medidata’s capabilities to integrate data from wearable sensors –
including clinical grade metrics – in clinical trials. - With this acquisition, Medidata’s integrated offering
will help provide life sciences companies and device
Read More
AiCure Launches Platform to Remotely Capture Digital Biomarkers in Clinical Trials
What You Should Know: - AiCure launches digital biomarker platform to remotely detect subtle changes in a patient's condition, leverages computer vision and AI to gather and analyze visual and auditory cues directly through the patient's smartphone camera. - AiCure appoints Ed Ikeguchi, M.D. as its Chief Executive Officer (CEO) to advance AiCure's commitment to improving holistic health through an understanding of the science behind human responses to illness and treatment. AiCure,
Read More
Mercom: Global Digital Health VC Funding Down 6% at $8.9B in 2019
- New Mercom Capital annual report reveals global venture capital (VC) funding in digital health declined 6% at $8.9B compared to $9.5B in 2018. - Total corporate funding into Digital Health – including VC funding, debt, and public market funding - dropped 18% to $10.6 billion in 2019 compared to $13 billion in 2018.- Five digital health IPOs brought in a total of $1.4 billion in 2019Global venture capital (VC) funding in digital health, including private equity and corporate venture, declined
Read More
